- Visibility 96 Views
- Downloads 57 Downloads
- Permissions
- DOI 10.18231/j.ijirm.2019.025
-
CrossMark
- Citation
Study on the utility of serum uric acid to creatinine ratio in the management of patients with chronic obstructive pulmonary disease (COPD)
- Author Details:
-
Dishan P.Y
-
Yuvarajan S *
-
Praveen R
-
Antonious Maria Selvam
Background: Chronic Obstructive Pulmonary Disease (COPD), is preventable and treatable disease which poses significant public health challenge. The impact of COPD on an individual patient doesn’t depend solely on the severity of airway obstruction, but also on the progression of clinical symptoms. A significant number of COPD patients suffer from tissue hypoxia and impaired oxidative metabolism. Hence this study was done to assess the progression of the disease by measuring the level of serum uric acid (UA) and serum uric acid to creatinine ratio (UA/Cr) in these patients.
Methodology: This hospital based cross sectional study was carried out in the department of Respiratory Medicine, in a tertiary care hospital from September 2017 to December 2018 on sixty COPD patients. Serum uric acid and creatinine were assessed with the Uricase and Modified Jaffe’s method respectively. Finally serum uric acid creatinine ratio was calculated.
Results: The mean level of serum uric acid (UA) in COPD patients with mild, moderate, severe and very severe obstruction were 2.62(mg/dl), 3.81(mg/dl), 4.53(mg/dl) and 5.72(mg/dl) respectively. The levels of serum uric acid to creatinine ratio in patients with mild, moderate, severe and very severe obstruction were in the mean of 2.24, 3.60, 5.12, and 8.12 respectively. Thus, both serum uric acid levels and serum uric acid to creatinine ratio increased with increase in the severity of airflow obstruction in patients with stable COPD which was statistically significant (p<0>
Conclusions: Thus, the levels of serum uric acid and serum UA/Cr ratio is raised in stable COPD patients and correlates with severity of airway obstruction. Thus serum UA/Cr ratio can be a useful marker to monitor the disease severity in addition to spirometric parameters like FVC, FEV1 and FEV1/FVC.
Keywords: Serum uric acid, Serum uric acid creatinine ratio, COPD.
References
- Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease Revised. 2013;1-3
- Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease Revised. 2015;5.
- Salvi S, Agarwal A. India needs a National COPD Prevention and Control Programme. Suppl JAPI. 2012;60:5-6.
- Health Status Maharashtra 2009: A report by the State Health Systems Resource Centre. 2010;20-21.
- Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006;48:23-7.
- Garcia Pachon E, Padilla Navas I, Shum C. Serum Uric Acid to Creatinine Ratio in Patients with Chronic Obstructive Pulmonary Disease. Lung. 2007;185(1)21-4.
- Samareh-Fekri M, Khorasani SAR, Shadkam-Farokhi M. Correlation of CRP and Serum Fibrinogen Levels with Disease Severity,clinical factors and Pulmonary Function Tests in COPD Patients. Tanafoss 2010;9(1):28-33.
- Willemse WM, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyper responsiveness and inflammation. Eur Respir J 2004;23:464-76.
- Moss DW. Methodological principles in the enzymatic determination of substrates illustrated by the measurement of uric acid. Clin Chim Acta 1980;105:351.
- Jaffe, M., Uber den Niederschlag welchen Pikrinsaure in normalen Harn erzengt und Uber eine neue Reaktio de sKreatinins, Z. Physiol Chem 1886;10;391-400.
- Mahesh PA, Jayaraj BS, Prahlad ST. Validation of a structured questionnaire for COPD and prevalence of COPD in rural area of Mysore: A pilot study. Lung India. 2009;3:63-9.
- Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691-5.
- Bednarek M, Maciejewski J, Wozniak M. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008;63(5):402-7.
- Vig A. Prevalence of Chronic Obstructive Pulmonary Disease in Patients attending a Chest Clinic in a Tertiary Care Hospital. Chest 2005;2:3.
- Montes de Oca M, Talamo C, Perez-Padilla R, Jardim JR, Muino A, Lopez MV et al. PLATINO Team. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med 2008;102(5):642-50.
- De S Body mass index among patient with chronic obstructive pulmonary diseases. Indian J Physiol Pharmacol 2012;56(4):353-8.
- Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007:9(5):518-24.
- Hunninghake DB. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:44–9.
- Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007:370(9589):797-9.
- Ruggiero C, Cherubini A, Miller E, 3rd, Maggio M, Najjar SS, Lauretani F, Bandinelli S, Senin U, Ferrucci L. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3year period in Italians aged 21 to 98 years. Am J Cardiol 2007:100(1):115-21. Dishan P.Y et al. Study on the utility of serum uric acid to creatinine ratio in the management of patients… IP Indian Journal of Immunology and Respiratory Medicine, April-June, 2019;4(2):109-113 113
- Inocencio H. Lopez Serum Uric Acid Levels Among Patients With Chronic Obstructive Pulmonary Disease. Chest 2003;10;124.
- Bartziokas K, Papaioannou AI, Loukides S. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J 2014;43:43–53.
- Ibrahim OCAK, Hayrettin Gocmen, Ahmet Ursavas, Duygu Koprucoglu, Dilek Cetiner Bahcetepe, Esin Tasas et al. The relationship of serum uric acid and uric acid to creatinine ratio with severity of exacerbations and arterial blood gases in COPD acute exacerbation 2010;24:93-100.
- Marangella M. Uric acid elimination in the urine. Pathophysiological implications. Contrib Nephrol 2005;147:132–48.
- Braghiroli A, Sacco C, Erbetta M. Overnight urinary acid/creatinine ratio for detection of sleep hypoxemia: validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993;148:173–8.
- Sato N, Kurashima K, Ubukata M, et al. Prognostic significance of serum uric acid in patients with chronic obstructive pulmonary disease receiving home oxygen therapy. Nihon Kokyuki Gakkai Zasshi 2003;41(2):74-80.
How to Cite This Article
Vancouver
P.Y D, S Y, R P, Selvam AM. Study on the utility of serum uric acid to creatinine ratio in the management of patients with chronic obstructive pulmonary disease (COPD) [Internet]. IP Indian J Immunol Respir Med. 2019 [cited 2025 Oct 06];4(2):109-113. Available from: https://doi.org/10.18231/j.ijirm.2019.025
APA
P.Y, D., S, Y., R, P., Selvam, A. M. (2019). Study on the utility of serum uric acid to creatinine ratio in the management of patients with chronic obstructive pulmonary disease (COPD). IP Indian J Immunol Respir Med, 4(2), 109-113. https://doi.org/10.18231/j.ijirm.2019.025
MLA
P.Y, Dishan, S, Yuvarajan, R, Praveen, Selvam, Antonious Maria. "Study on the utility of serum uric acid to creatinine ratio in the management of patients with chronic obstructive pulmonary disease (COPD)." IP Indian J Immunol Respir Med, vol. 4, no. 2, 2019, pp. 109-113. https://doi.org/10.18231/j.ijirm.2019.025
Chicago
P.Y, D., S, Y., R, P., Selvam, A. M.. "Study on the utility of serum uric acid to creatinine ratio in the management of patients with chronic obstructive pulmonary disease (COPD)." IP Indian J Immunol Respir Med 4, no. 2 (2019): 109-113. https://doi.org/10.18231/j.ijirm.2019.025